The upward trend could spur Synergy Healthcare in coming sessions.

The group displays strong fundamentals. Growth and profitability prospects are encouraging with revenues reaching GBP 420 million this year for a net margin close to 9.5%. Moreover, better results are expected for the coming years.

Graphically, buyers influence has been downsized. The stock is currently in an accumulation phase close to a support level. This area offers an interesting entry point as the share should accelerate in the coming sessions. Weekly moving averages are still well-oriented and support the price progression.

Investors should closely monitor the security near GBp 1352, to take advantage of renewed upward acceleration in the direction of GBp 1458. A stop loss will be placed under GBp 1337.